RecruitingNot ApplicableNCT07196852

Redox Status and Exercise Training-induced Adaptations

Effects of N-acetylcysteine on Biological Responses to High-intensity Interval Training in Adults With Overweight/Obesity


Sponsor

University of Thessaly

Enrollment

60 participants

Start Date

Sep 22, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Excess fat accumulation is a key feature of overweight and obesity that is mainly driven by nutrient overload and insufficient physical activity. White adipose tissue displays lipid overload and hypertrophy accompanied by macrophages infiltration, hypoxia, inflammation and excess production of reactive oxygen species (ROS). An inflammatory response and ROS production are also evident in other metabolism regulating tissues and organs such as skeletal muscle, liver, pancreas and hypothalamus, contributing to a chronic inflammatory state, redox status disturbances and metabolic complications. There is overwhelming evidence showing that adults with overweight/obesity exhibit lower glutathione (GSH) levels in blood erythrocytes, skeletal muscle cells and subcutaneous and visceral adipose tissue cells. GSH, a tripeptide consisting of the amino acids glutamate, cysteine and glycine, is the most abundant thiol-containing antioxidant in the human body and has been, recently, characterized as a novel therapeutic target for the treatment of numerous chronic diseases, due to its potent intracellular redox buffering capacity. Interestingly, lower GSH levels have been associated with diet-induced weight loss resistance, while enhancement of GSH levels through N-acetylcysteine (NAC) supplementation reduces markers of oxidative stress, inflammation, insulin resistance, hypertension, endothelia dysfunction and improves vitamin D metabolism. NAC is a thiol donor that elicits antioxidant effects by (i) directly scavenging ROS and (ii) providing reduced cysteine through deacetylation, which supports the biosynthesis of endogenous GSH via the activity of γ-glutamylcysteine synthase. The aim of this study is to investigate whether NAC supplementation can enhance the exercise training-induced improvements on physical fitness and metabolic health in adult men and women with overweight/obesity.


Eligibility

Min Age: 30 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study investigates whether taking N-acetylcysteine (NAC) — an antioxidant supplement that boosts the body's own glutathione defenses — during a 12-week high-intensity interval training program improves fitness, body composition, and metabolic health more than exercise alone in overweight or obese adults. Obesity is associated with reduced glutathione levels, which may limit the benefits of exercise. Adults aged 35–45 with a BMI between 25 and 35 who are free of chronic diseases, not on any medications or supplements, and are non-smokers may be eligible. Participation involves attending 3 exercise sessions per week for 12 weeks, taking two NAC (or placebo) capsules daily, and completing body composition scans, fitness tests, blood draws, and dietary recalls at the start, middle, and end of the program. This summary was generated with AI assistance and is intended to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTN Acetyl L Cysteine

Participants will participate in 3 multicomponent high-intensity interval training (m-HIIT) sessions per week over a 12-week period while receiving daily 1200 mg N-acetylcysteine (2 pills x 600 mg/day ).

DIETARY_SUPPLEMENTPlacebo

Participants will participate in 3 multicomponent high-intensity interval training (m-HIIT) sessions per week over a 12-week period while receiving daily 2 placebo pills/day.


Locations(1)

Department of Physical Education and Sport Science, University of Thessaly

Trikala, Karies, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07196852


Related Trials